Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Neoplasms 3Prostatic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Ovarian Neoplasms 1Ototoxicity 1Heart Failure 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Cardiovascular Diseases 1Cardiotoxicity 1Atherosclerosis 1

Interventions

Docetaxel 277Prednisone 237enzalutamide 177Leuprolide 172Radiotherapy 164Abiraterone Acetate 154Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 79abiraterone 77gallium 68 PSMA-11 74Specimen Handling 67darolutamide 58Gonadotropin-Releasing Hormone 58Radiation 56Triptorelin Pamoate 53cabazitaxel 50Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all
NCT03127631 2025-01-31

RADICALPC

McMaster University

Phase NA Recruiting
6,000 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

NCT00572468 2017-07-13

Statin Therapy Versus Placebo Prior to Prostatectomy

VA Office of Research and Development

Phase NA Completed
42 enrolled 9 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡